Leffler Scott J.
SEC CIK 1832406 · EDGAR
Most active insiders at MYGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Phanstiel S. Louise | Dir | $494.5K | — |
| 2 | Raha Samraat S. | Pres, CEO, Dir | $200.0K | — |
| 3 | Kumar Rashmi | Dir | — | $66.8K |
| 4 | Bisaro Paul | Dir | $27.6K | — |
| 5 | Jampa Raj | CTO | — | — |
| 6 | Wheeler Benjamin Richard | CFO | — | — |
| 7 | Donnelly Brian J | Chief Commerical Off | — | — |
| 8 | Davis Mark Steven | Dir | — | — |
| 9 | Sikri Vishal | EVP, Commercial | — | — |
| 10 | Muzzey Dale | CSO | — | — |
Leffler Scott J. made no open-market trades at MYGN in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-17 | 2025-03-13 | MYGN | MYRIAD GENETICS INC | Leffler Scott J. | CFO | A - Grant | $0.00 | +72.2K | 224.6K | +47% | $0 | |
| 2025-03-17 | 2025-03-14 | MYGN | MYRIAD GENETICS INC | Leffler Scott J. | CFO | F - Tax | $10.07 | -6,217 | 218.4K | -3% | -$62.6K | |
| 2025-01-30 | 2025-01-29 | MYGN | MYRIAD GENETICS INC | Leffler Scott J. | CFO | F - Tax | $12.54 | -12.2K | 152.4K | -7% | -$153.4K | |
| A | 2024-03-28 | 2024-03-14 | MYGN | MYRIAD GENETICS INC | Leffler Scott J. | CFO | A - Grant | $0.00 | +46.9K | 164.7K | +40% | $0 |
| 2024-03-18 | 2024-03-14 | MYGN | MYRIAD GENETICS INC | Leffler Scott J. | CFO | A - Grant | $0.00 | +46.1K | 163.9K | +39% | $0 | |
| 2024-01-29 | 2024-01-25 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Leffler Scott J. | CFO | F - Tax | $0.98 | -83.5K | 4.86M | -2% | -$81.9K | |
| 2024-01-29 | 2024-01-29 | MYGN | MYRIAD GENETICS INC | Leffler Scott J. | CFO | A - Grant | $0.00 | +117.8K | 117.8K | New | $0 | |
| 2023-11-02 | 2023-10-31 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Leffler Scott J. | CFO | A - Grant | $0.00 | +400.0K | 4.94M | +9% | $0 | |
| 2023-10-27 | 2023-10-25 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Leffler Scott J. | CFO | F - Tax | $0.91 | -124.0K | 4.54M | -3% | -$112.8K | |
| 2023-07-26 | 2023-07-25 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Leffler Scott J. | CFO | F - Tax | $1.09 | -387.2K | 4.66M | -8% | -$422.0K | |
| 2022-07-26 | 2022-07-25 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Leffler Scott J. | CFO | A - Grant | $0.00 | +5.04M | 5.05M | +50,420% | $0 | |
| D | 2022-03-04 | 2022-03-02 | SHC | Sotera Health Co | Leffler Scott J. | CFO, Treas | A - Grant | $0.00 | +37.4K | 738.6K | +5% | $0 |
| 2021-11-23 | 2021-11-20 | SHC | Sotera Health Co | Leffler Scott J. | CFO, Treas | F - Tax | $22.54 | -3,894 | 701.2K | -0.6% | -$87.8K |
Purchase Sale Sale after option exercise All abbreviations